EDMOND DE ROTHSCHILD HOLDING S.A. - REPROS THERAPEUTICS INC ownership

REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 57 filers reported holding REPROS THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q3 2015$1,403,000
+3.9%
285,500
+1.1%
0.04%
+20.7%
Q2 2015$1,350,000282,5000.03%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$9,727,0002.05%
RTW INVESTMENTS, LP 229,364$1,970,0000.89%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 361,300$3,104,0000.85%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,826,0000.73%
SENZAR ASSET MANAGEMENT, LLC 244,006$2,096,0000.51%
GENERAL AMERICAN INVESTORS CO INC 508,375$4,367,0000.36%
CQS Cayman LP 700,000$6,013,0000.28%
Rotella Capital Management, Inc. 20,800$179,0000.15%
Baker Brothers Advisors 2,000,000$17,180,0000.14%
Gruss Capital Management LP 304,000$2,611,0000.11%
View complete list of REPROS THERAPEUTICS INC shareholders